Acurx Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

Analyst price target for ACXP

Based on 1 analyst offering 12 month price targets for Acurx Pharmaceuticals Inc.
Min Forecast
Avg Forecast
Max Forecast

Should I buy or sell ACXP stock?

Based on 1 analyst offering ratings for Acurx Pharmaceuticals Inc.
Strong Buy
0 analysts 0%
1 analysts 100%
0 analysts 0%
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ACXP stock forecasts and price targets.

ACXP stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
HC Wainwright & Co.
Top 8%

1 of 1

ACXP vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
PPBT$1.70$9.00+429.41%Strong Buy
EVAX$1.41$7.00+396.45%Strong Buy

Acurx Pharmaceuticals Stock Forecast FAQ

Is Acurx Pharmaceuticals Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: ACXP) stock is to Buy ACXP stock.

Out of 1 analyst, 0 (0%) are recommending ACXP as a Strong Buy, 1 (100%) are recommending ACXP as a Buy, 0 (0%) are recommending ACXP as a Hold, 0 (0%) are recommending ACXP as a Sell, and 0 (0%) are recommending ACXP as a Strong Sell.

If you're new to stock investing, here's how to buy Acurx Pharmaceuticals stock.

What is ACXP's Price Target?

According to 1 Wall Street analyst that have issued a 1 year ACXP price target, the average ACXP price target is $14.00, with the highest ACXP stock price forecast at $14.00 and the lowest ACXP stock price forecast at $14.00.

The Wall Street analyst predicted that Acurx Pharmaceuticals's share price could reach $14.00 by May 15, 2024. The average Acurx Pharmaceuticals stock price prediction forecasts a potential upside of 382.76% from the current ACXP share price of $2.90.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.